| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | CABP2 FBLN5 CALR PCDHB9 CUBN PKD1L2 SVEP1 RYR1 RYR3 LRP8 THBS1 EYS FBN2 UMODL1 CADPS LRP1 CD69 DSG4 LTBP3 PLS3 NOTCH2 NOTCH4 | 7.03e-07 | 749 | 175 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | PDXDC1 NPHS1 FBLN5 CALR ADAM20 LAMA5 ITGB8 SVEP1 DDX3X THBS1 WASF2 FGFR1 HSPA1A SLC14A2 PLXNB3 CNTN1 | 7.84e-05 | 599 | 175 | 16 | GO:0050839 |
| GeneOntologyMolecularFunction | myosin VI binding | 2.28e-04 | 3 | 175 | 2 | GO:0070853 | |
| GeneOntologyMolecularFunction | very-long-chain fatty acyl-CoA dehydrogenase activity | 2.28e-04 | 3 | 175 | 2 | GO:0017099 | |
| GeneOntologyMolecularFunction | denatured protein binding | 2.28e-04 | 3 | 175 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | NF-kappaB binding | 2.70e-04 | 36 | 175 | 4 | GO:0051059 | |
| GeneOntologyMolecularFunction | long-chain fatty acyl-CoA dehydrogenase activity | 4.53e-04 | 4 | 175 | 2 | GO:0004466 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 4.53e-04 | 4 | 175 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 7.51e-04 | 5 | 175 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | receptor signaling protein tyrosine kinase activator activity | 7.51e-04 | 5 | 175 | 2 | GO:0030298 | |
| GeneOntologyMolecularFunction | integrin binding | 9.06e-04 | 175 | 175 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.12e-03 | 6 | 175 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.12e-03 | 6 | 175 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 1.12e-03 | 6 | 175 | 2 | GO:0055131 | |
| GeneOntologyMolecularFunction | CTPase activity | 1.12e-03 | 6 | 175 | 2 | GO:0043273 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | ERBB2 CEACAM5 FSTL3 OFD1 USP9X WNT5A LMTK2 AKAP3 USP9Y ERBIN ITGB8 SVEP1 RYR1 MAP3K1 TGFB1I1 ZFYVE28 THBS1 AKAP4 FBN2 NFIA CPNE3 LRP1 DSG4 FGFR1 LTBP3 LTK HSPA1A ALK NOTCH2 RNF111 ANKS1A | 1.96e-08 | 1186 | 175 | 31 | GO:0007167 |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | FSTL3 USP9X WNT5A AKAP3 USP9Y ITGB8 RYR1 MAP3K1 TGFB1I1 THBS1 AKAP4 FBN2 NFIA LRP1 DSG4 LTBP3 HSPA1A NOTCH2 RNF111 | 3.05e-08 | 482 | 175 | 19 | GO:0007178 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | FSTL3 USP9X WNT5A USP9Y ITGB8 RYR1 MAP3K1 TGFB1I1 THBS1 FBN2 NFIA LRP1 DSG4 LTBP3 HSPA1A NOTCH2 RNF111 | 2.63e-07 | 445 | 175 | 17 | GO:0141091 |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | ERBB2 RELN CEACAM5 RIPK3 WNT5A MAP3K1 DDX3X LRP8 CEMIP FZD8 THBS1 FZD5 FGFR1 LTK ALK NOTCH2 | 3.86e-07 | 405 | 175 | 16 | GO:0033674 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | ERBB2 FSTL3 OFD1 USP9X WNT5A LMTK2 USP9Y ITGB8 RYR1 MAP3K1 LRP8 TGFB1I1 THBS1 FBN2 NFIA CPNE3 LRP1 DSG4 FGFR1 LTBP3 HSPA1A NOTCH2 RNF111 | 9.09e-07 | 850 | 175 | 23 | GO:0071363 |
| GeneOntologyBiologicalProcess | response to growth factor | ERBB2 FSTL3 OFD1 USP9X WNT5A LMTK2 USP9Y ITGB8 RYR1 MAP3K1 LRP8 TGFB1I1 THBS1 FBN2 NFIA CPNE3 LRP1 DSG4 FGFR1 LTBP3 HSPA1A NOTCH2 RNF111 | 1.74e-06 | 883 | 175 | 23 | GO:0070848 |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | ERBB2 RELN CEACAM5 RIPK3 WNT5A MAP3K1 DDX3X LRP8 CEMIP FZD8 THBS1 FZD5 FGFR1 NOTCH2 | 1.83e-06 | 350 | 175 | 14 | GO:0045860 |
| GeneOntologyBiologicalProcess | cell junction organization | NPHS1 ERBB2 RELN CEACAM5 USP9X WNT5A PCDHB9 LAMA5 IGSF11 PLXND1 SVEP1 LRP8 THBS1 NFIA FZD5 WASF2 CAPRIN2 LRP1 FGFR1 C5AR1 MDGA1 ALOX12B SEZ6L TBX5 | 2.66e-06 | 974 | 175 | 24 | GO:0034330 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | USP9X USP9Y ITGB8 RYR1 MAP3K1 TGFB1I1 THBS1 FBN2 LRP1 LTBP3 HSPA1A RNF111 | 4.40e-06 | 276 | 175 | 12 | GO:0007179 |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | ERBB2 RELN CEACAM5 RIPK3 WNT5A MAP3K1 DDX3X LRP8 CEMIP FZD8 THBS1 FZD5 FGFR1 LTK ALK NOTCH2 | 4.60e-06 | 490 | 175 | 16 | GO:0051347 |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | ERBB2 CEACAM5 WNT5A MAP3K1 DDX3X CEMIP FZD8 THBS1 FZD5 FGFR1 | 6.12e-06 | 193 | 175 | 10 | GO:0071902 |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | RELN WNT5A LRP8 CAPRIN2 LRP1 ATF1 FGFR1 LTK ALK PLXNB3 CNTN1 | 9.57e-06 | 249 | 175 | 11 | GO:0010976 |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 1.46e-05 | 129 | 175 | 8 | GO:0043406 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | ERBB2 RELN CEACAM5 RIPK3 PLEKHG4 WNT5A TBC1D2B CASP8 MAP3K1 DDX3X LRP8 CEMIP FZD8 TBC1D10C MSH6 THBS1 P2RX1 FZD5 FGFR1 LTK HSPA1A ALK NOTCH2 | 2.07e-05 | 1028 | 175 | 23 | GO:0043085 |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | ERBB2 FBLN5 CEACAM5 WNT5A E2F7 CASP8 HIF3A PLXND1 ITGB8 PLCD3 FZD8 THBS1 FZD5 WASF2 LRP1 FGFR1 C5AR1 NOTCH2 NOTCH4 TBX5 | 2.13e-05 | 817 | 175 | 20 | GO:0048514 |
| GeneOntologyBiologicalProcess | regulation of kinase activity | ERBB2 RELN CEACAM5 RIPK3 WNT5A MAP3K1 DDX3X LRP8 CEMIP ZFYVE28 FZD8 THBS1 FZD5 FGFR1 C5AR1 LTK ALK NOTCH2 | 2.28e-05 | 686 | 175 | 18 | GO:0043549 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | ERBB2 RELN CEACAM5 RIPK3 PLEKHG4 USP9X WNT5A TBC1D2B CASP8 PLXND1 MAP3K1 DDX3X LRP8 CEMIP FZD8 TBC1D10C MSH6 THBS1 P2RX1 FZD5 LRP1 FGFR1 LTK ATP1B3 HSPA1A HSPA1B ALK NOTCH2 | 2.80e-05 | 1430 | 175 | 28 | GO:0044093 |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | USP9X USP9Y ITGB8 RYR1 MAP3K1 TGFB1I1 THBS1 FBN2 LRP1 LTBP3 HSPA1A RNF111 | 3.14e-05 | 336 | 175 | 12 | GO:0071560 |
| GeneOntologyBiologicalProcess | axon guidance | ERBB2 RELN PLEKHG4 WNT5A LAMA2 LMTK2 LAMA5 SEMA5B LRP1 NOTCH2 CNTN1 | 3.35e-05 | 285 | 175 | 11 | GO:0007411 |
| GeneOntologyBiologicalProcess | angiogenesis | ERBB2 FBLN5 CEACAM5 WNT5A E2F7 CASP8 HIF3A PLXND1 ITGB8 PLCD3 FZD8 THBS1 FZD5 WASF2 FGFR1 C5AR1 NOTCH2 NOTCH4 | 3.45e-05 | 708 | 175 | 18 | GO:0001525 |
| GeneOntologyBiologicalProcess | neuron projection guidance | ERBB2 RELN PLEKHG4 WNT5A LAMA2 LMTK2 LAMA5 SEMA5B LRP1 NOTCH2 CNTN1 | 3.45e-05 | 286 | 175 | 11 | GO:0097485 |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | USP9X USP9Y ITGB8 RYR1 MAP3K1 TGFB1I1 THBS1 FBN2 LRP1 LTBP3 HSPA1A RNF111 | 3.83e-05 | 343 | 175 | 12 | GO:0071559 |
| GeneOntologyBiologicalProcess | regulation of transferase activity | ERBB2 RELN CEACAM5 RIPK3 WNT5A MAP3K1 DDX3X LRP8 CEMIP ZFYVE28 FZD8 THBS1 FZD5 EIF4A2 FGFR1 C5AR1 LTK ALK NOTCH2 | 6.14e-05 | 810 | 175 | 19 | GO:0051338 |
| GeneOntologyBiologicalProcess | regulation of protein kinase activity | ERBB2 RELN CEACAM5 RIPK3 WNT5A MAP3K1 DDX3X LRP8 CEMIP ZFYVE28 FZD8 THBS1 FZD5 FGFR1 C5AR1 NOTCH2 | 6.79e-05 | 611 | 175 | 16 | GO:0045859 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | HEXA ERBB2 RELN PLEKHG4 USP9X WNT5A LAMA2 LMTK2 LAMA5 PLXND1 LRP8 SEMA5B CAPRIN2 LRP1 RPL4 NOTCH2 PLXNB3 CNTN1 | 7.00e-05 | 748 | 175 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell morphogenesis | HEXA ERBB2 RELN METTL3 PLEKHG4 USP9X WNT5A LAMA2 LMTK2 LAMA5 PLXND1 MAP3K1 LRP8 YPEL4 SEMA5B NFIA WASF2 CAPRIN2 LRP1 RPL4 NOTCH2 PLXNB3 NOTCH4 CNTN1 | 7.46e-05 | 1194 | 175 | 24 | GO:0000902 |
| GeneOntologyBiologicalProcess | vasculature development | ERBB2 FBLN5 CEACAM5 WNT5A E2F7 CASP8 HIF3A PLXND1 ITGB8 SVEP1 PLCD3 FZD8 THBS1 FZD5 WASF2 LRP1 FGFR1 C5AR1 NOTCH2 NOTCH4 TBX5 | 7.68e-05 | 969 | 175 | 21 | GO:0001944 |
| GeneOntologyBiologicalProcess | synapse organization | ERBB2 RELN USP9X WNT5A PCDHB9 LAMA5 IGSF11 PLXND1 LRP8 NFIA FZD5 WASF2 CAPRIN2 FGFR1 C5AR1 MDGA1 SEZ6L | 7.73e-05 | 685 | 175 | 17 | GO:0050808 |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | RELN WNT5A PLXND1 LRP8 WASF2 CAPRIN2 LRP1 ATF1 FGFR1 LTK RPL4 ALK PLXNB3 CNTN1 | 8.59e-05 | 494 | 175 | 14 | GO:0031346 |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 9.42e-05 | 11 | 175 | 3 | GO:0070432 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | ERBB2 RELN METTL3 SRSF1 LAMA2 NFIA LRP1 MIOS C5AR1 NOTCH2 CNTN1 | 9.74e-05 | 321 | 175 | 11 | GO:0010001 |
| GeneOntologyBiologicalProcess | axonogenesis | ERBB2 RELN PLEKHG4 USP9X WNT5A LAMA2 LMTK2 LAMA5 PLXND1 SEMA5B LRP1 RPL4 NOTCH2 PLXNB3 CNTN1 | 1.01e-04 | 566 | 175 | 15 | GO:0007409 |
| GeneOntologyBiologicalProcess | neuron development | HEXA ERBB2 RELN PLEKHG4 USP9X WNT5A LAMA2 LMTK2 LAMA5 PLXND1 CSMD3 LRP8 RND1 SEMA5B OTOGL CAPRIN2 LRP1 MTR ATF1 FGFR1 LTK RPL4 ALK NOTCH2 PLXNB3 CNTN1 ANKS1A | 1.08e-04 | 1463 | 175 | 27 | GO:0048666 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | ERBB2 RELN CEACAM5 RIPK3 WNT5A MAP3K1 DDX3X LRP8 CEMIP FZD8 THBS1 FZD5 FGFR1 LTK ALK IQGAP3 NOTCH2 CNTN1 | 1.19e-04 | 780 | 175 | 18 | GO:0042327 |
| GeneOntologyBiologicalProcess | axon development | ERBB2 RELN PLEKHG4 USP9X WNT5A LAMA2 LMTK2 LAMA5 PLXND1 SEMA5B LRP1 MTR RPL4 NOTCH2 PLXNB3 CNTN1 | 1.21e-04 | 642 | 175 | 16 | GO:0061564 |
| GeneOntologyBiologicalProcess | blood vessel development | ERBB2 FBLN5 CEACAM5 WNT5A E2F7 CASP8 HIF3A PLXND1 ITGB8 PLCD3 FZD8 THBS1 FZD5 WASF2 LRP1 FGFR1 C5AR1 NOTCH2 NOTCH4 TBX5 | 1.26e-04 | 929 | 175 | 20 | GO:0001568 |
| GeneOntologyBiologicalProcess | cell activation | ERBB2 METTL3 CEACAM5 RIPK3 IMPDH1 WNT5A VSIG4 CASP8 WDFY4 ALKBH5 ITGB8 SVEP1 FZD8 TBC1D10C MSH6 THBS1 TXLNA ICOS P2RX1 FZD5 LRP1 FGFR1 C5AR1 NOTCH2 KPNA1 | 2.03e-04 | 1356 | 175 | 25 | GO:0001775 |
| GeneOntologyBiologicalProcess | syncytiotrophoblast cell differentiation involved in labyrinthine layer development | 2.14e-04 | 3 | 175 | 2 | GO:0060715 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ERBB2 RELN PLEKHG4 USP9X WNT5A LAMA2 LMTK2 LAMA5 PLXND1 LRP8 SEMA5B WASF2 CAPRIN2 LRP1 RPL4 NOTCH2 PLXNB3 CNTN1 | 2.17e-04 | 819 | 175 | 18 | GO:0120039 |
| GeneOntologyBiologicalProcess | tube morphogenesis | ERBB2 FBLN5 CEACAM5 WNT5A E2F7 LAMA5 CASP8 HIF3A PLXND1 ITGB8 PLCD3 FZD8 THBS1 FZD5 WASF2 LRP1 FGFR1 C5AR1 CSMD1 NOTCH2 NOTCH4 TBX5 | 2.25e-04 | 1125 | 175 | 22 | GO:0035239 |
| GeneOntologyBiologicalProcess | neuron projection development | ERBB2 RELN PLEKHG4 USP9X WNT5A LAMA2 LMTK2 LAMA5 PLXND1 CSMD3 LRP8 SEMA5B OTOGL CAPRIN2 LRP1 MTR ATF1 FGFR1 LTK RPL4 ALK NOTCH2 PLXNB3 CNTN1 | 2.27e-04 | 1285 | 175 | 24 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ERBB2 RELN PLEKHG4 USP9X WNT5A LAMA2 LMTK2 LAMA5 PLXND1 LRP8 SEMA5B WASF2 CAPRIN2 LRP1 RPL4 NOTCH2 PLXNB3 CNTN1 | 2.40e-04 | 826 | 175 | 18 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of MAP kinase activity | 2.58e-04 | 194 | 175 | 8 | GO:0043405 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular signal transduction | ERBB2 RELN CEACAM5 RIPK3 CALR USP9X WNT5A CASP8 GRM1 MAP3K1 DDX3X FZD8 THBS1 FZD5 LRP1 MIOS FGFR1 C5AR1 LTK HSPA1A HSPA1B IQGAP3 ALOX12B NOTCH2 | 2.67e-04 | 1299 | 175 | 24 | GO:1902533 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | FNDC3B RELN CEACAM5 WNT5A LAMA2 CASP8 PLXND1 LRP8 TGFB1I1 FBN2 CAPRIN2 LRP1 NCOA1 FGFR1 LTBP3 HSPA1A HSPA1B RPL4 NOTCH2 PLXNB3 NOTCH4 TBX5 | 2.73e-04 | 1141 | 175 | 22 | GO:0045597 |
| GeneOntologyBiologicalProcess | placenta development | 2.86e-04 | 197 | 175 | 8 | GO:0001890 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 3.10e-04 | 16 | 175 | 3 | GO:0070424 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | NPHS1 ERBB2 RELN FBLN5 CEACAM5 WNT5A E2F7 CASP8 HIF3A PLXND1 ITGB8 LRP8 PLCD3 FZD8 THBS1 FBN2 FZD5 WASF2 MIOS FGFR1 C5AR1 ERVS71-1 NOTCH2 NOTCH4 CNTN1 TBX5 | 3.28e-04 | 1483 | 175 | 26 | GO:0048646 |
| GeneOntologyBiologicalProcess | tube development | FNDC3B ERBB2 FBLN5 CEACAM5 WNT5A E2F7 LAMA5 CASP8 HIF3A PLXND1 ITGB8 PLCD3 FZD8 THBS1 NFIA FZD5 WASF2 LRP1 FGFR1 LTBP3 C5AR1 CSMD1 NOTCH2 NOTCH4 TBX5 | 3.36e-04 | 1402 | 175 | 25 | GO:0035295 |
| GeneOntologyBiologicalProcess | gliogenesis | ERBB2 RELN METTL3 SRSF1 LAMA2 LRP8 NFIA LRP1 MIOS C5AR1 NOTCH2 CNTN1 | 3.54e-04 | 435 | 175 | 12 | GO:0042063 |
| GeneOntologyBiologicalProcess | cell junction assembly | NPHS1 RELN USP9X WNT5A PCDHB9 IGSF11 PLXND1 THBS1 FZD5 LRP1 FGFR1 MDGA1 ALOX12B TBX5 | 3.68e-04 | 569 | 175 | 14 | GO:0034329 |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | ERBB2 CEACAM5 WNT5A GRM1 MAP3K1 FZD8 THBS1 FZD5 LRP1 FGFR1 C5AR1 IQGAP3 ALOX12B NOTCH2 | 3.81e-04 | 571 | 175 | 14 | GO:0043410 |
| GeneOntologyBiologicalProcess | presynapse organization | 3.91e-04 | 73 | 175 | 5 | GO:0099172 | |
| GeneOntologyBiologicalProcess | negative regulation of cell junction assembly | 3.97e-04 | 41 | 175 | 4 | GO:1901889 | |
| GeneOntologyBiologicalProcess | positive regulation of protein phosphorylation | ERBB2 RELN CEACAM5 RIPK3 WNT5A MAP3K1 DDX3X LRP8 CEMIP FZD8 THBS1 FZD5 FGFR1 IQGAP3 NOTCH2 CNTN1 | 4.62e-04 | 724 | 175 | 16 | GO:0001934 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ERBB2 RELN PLEKHG4 USP9X WNT5A LAMA2 LMTK2 LAMA5 PLXND1 LRP8 SEMA5B CAPRIN2 LRP1 RPL4 NOTCH2 PLXNB3 CNTN1 | 4.92e-04 | 802 | 175 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | ERBB2 RELN CEACAM5 RIPK3 WNT5A MAP3K1 DDX3X LRP8 CEMIP FZD8 THBS1 FZD5 FGFR1 LTK ALK IQGAP3 NOTCH2 CNTN1 | 5.04e-04 | 879 | 175 | 18 | GO:0010562 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | ERBB2 RELN CEACAM5 RIPK3 WNT5A MAP3K1 DDX3X LRP8 CEMIP FZD8 THBS1 FZD5 FGFR1 LTK ALK IQGAP3 NOTCH2 CNTN1 | 5.04e-04 | 879 | 175 | 18 | GO:0045937 |
| GeneOntologyBiologicalProcess | placenta blood vessel development | 5.22e-04 | 44 | 175 | 4 | GO:0060674 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | ERBB2 RELN METTL3 CEACAM5 RIPK3 WNT5A CASP8 MAP3K1 DDX3X LRP8 CEMIP TGFB1I1 FZD8 THBS1 P2RX1 FZD5 LRP1 FGFR1 HSPA1A HSPA1B IQGAP3 BOLL NOTCH2 CNTN1 RNF111 | 5.98e-04 | 1458 | 175 | 25 | GO:0051247 |
| GeneOntologyBiologicalProcess | regulation of cell migration | RELN CEACAM5 RIPK3 CALR WNT5A LAMA2 LAMA5 CASP8 PLXND1 MAP3K1 CEMIP THBS1 FBN2 SEMA5B CAPN7 CPNE3 NAV3 LRP1 FGFR1 C5AR1 PLXNB3 TBX5 | 6.13e-04 | 1211 | 175 | 22 | GO:0030334 |
| GeneOntologyBiologicalProcess | nucleotide-binding oligomerization domain containing 2 signaling pathway | 6.15e-04 | 20 | 175 | 3 | GO:0070431 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 7.04e-04 | 5 | 175 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | RELN WNT5A PLXND1 CSMD3 LRP8 CAPRIN2 LRP1 ATF1 FGFR1 LTK RPL4 ALK PLXNB3 CNTN1 | 7.53e-04 | 612 | 175 | 14 | GO:0010975 |
| GeneOntologyBiologicalProcess | sphingolipid metabolic process | 7.77e-04 | 176 | 175 | 7 | GO:0006665 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | FSTL3 WNT5A RYR1 TGFB1I1 THBS1 FBN2 LRP1 HSPA1A NOTCH2 RNF111 | 7.87e-04 | 347 | 175 | 10 | GO:0090092 |
| GeneOntologyBiologicalProcess | positive regulation of JUN kinase activity | 7.88e-04 | 49 | 175 | 4 | GO:0043507 | |
| GeneOntologyBiologicalProcess | skeletal system development | HEXA FBLN5 WNT5A LAMA5 ITGB8 RYR1 THBS1 FBN2 NFIA FGFR1 LTBP3 PLS3 NOTCH2 RAI1 | 7.89e-04 | 615 | 175 | 14 | GO:0001501 |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | DMXL2 METTL3 CALR ADAM20 WNT5A E2F7 CASP8 USP9Y ALKBH5 DDX3X MSH6 AKAP4 EHMT2 UMODL1 FZD5 CELF3 MOV10L1 NCOA1 DLEC1 HERC2 CSMD1 BOLL | 7.94e-04 | 1235 | 175 | 22 | GO:0003006 |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | FSTL3 OFD1 WNT5A RYR1 TGFB1I1 THBS1 FBN2 LRP1 HSPA1A NOTCH2 RNF111 | 8.13e-04 | 412 | 175 | 11 | GO:0090287 |
| GeneOntologyBiologicalProcess | gland morphogenesis | 8.30e-04 | 178 | 175 | 7 | GO:0022612 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | RELN WNT5A TBC1D2B PLXND1 CSMD3 LRP8 TBC1D10C WASF2 CAPRIN2 LRP1 ATF1 FGFR1 LTK RPL4 ALK PLXNB3 CNTN1 | 8.91e-04 | 846 | 175 | 17 | GO:0120035 |
| GeneOntologyBiologicalProcess | gland development | CEACAM5 SRSF1 RIPK3 WNT5A E2F7 LAMA5 PLXND1 NCOA1 FGFR1 CSMD1 IQGAP3 NOTCH2 NOTCH4 | 9.84e-04 | 558 | 175 | 13 | GO:0048732 |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 9.87e-04 | 52 | 175 | 4 | GO:0071526 | |
| GeneOntologyBiologicalProcess | regulation of protein serine/threonine kinase activity | ERBB2 CEACAM5 WNT5A MAP3K1 DDX3X CEMIP FZD8 THBS1 FZD5 FGFR1 | 9.97e-04 | 358 | 175 | 10 | GO:0071900 |
| GeneOntologyBiologicalProcess | cellular heat acclimation | 1.05e-03 | 6 | 175 | 2 | GO:0070370 | |
| GeneOntologyBiologicalProcess | regulation of Rab protein signal transduction | 1.05e-03 | 6 | 175 | 2 | GO:0032483 | |
| GeneOntologyBiologicalProcess | biological phase | 1.06e-03 | 53 | 175 | 4 | GO:0044848 | |
| GeneOntologyCellularComponent | external encapsulating structure | NPHS1 RELN FBLN5 ZAN CALR WNT5A LAMA2 LAMA5 SSPOP PKHD1L1 ERBIN SVEP1 TGFB1I1 THBS1 EYS FBN2 FCGBP OTOGL LTBP3 | 2.60e-06 | 658 | 174 | 19 | GO:0030312 |
| GeneOntologyCellularComponent | extracellular matrix | NPHS1 RELN FBLN5 ZAN CALR WNT5A LAMA2 LAMA5 SSPOP ERBIN SVEP1 TGFB1I1 THBS1 EYS FBN2 FCGBP OTOGL LTBP3 | 9.72e-06 | 656 | 174 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | receptor complex | ERBB2 CEACAM5 PLXND1 CUBN GRM1 ITGB8 LRP8 CSF2RB CAPRIN2 LRP1 FGFR1 LTK ALK NOTCH2 PLXNB3 | 1.09e-04 | 581 | 174 | 15 | GO:0043235 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | NPHS1 RELN FBLN5 CALR WNT5A LAMA2 LAMA5 SSPOP ERBIN TGFB1I1 THBS1 EYS FBN2 LTBP3 | 1.47e-04 | 530 | 174 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.52e-04 | 13 | 174 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | secretory granule | HEXA DMXL2 IMPDH1 FSTL3 ABCA13 CALR AKAP3 DDX3X NIT2 FZD8 TBC1D10C THBS1 P2RX1 CADPS CPNE3 LRP1 C5AR1 ALDH3B1 HSPA1A HSPA1B | 3.09e-04 | 1014 | 174 | 20 | GO:0030141 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ERBB2 CEACAM5 ERBIN WASF2 LRP1 C5AR1 ATP1B3 HSPA1A HSPA1B SLC14A2 | 3.62e-04 | 320 | 174 | 10 | GO:0016323 |
| GeneOntologyCellularComponent | basal plasma membrane | ERBB2 CEACAM5 ERBIN WASF2 LRP1 C5AR1 ATP1B3 HSPA1A HSPA1B SLC14A2 | 7.93e-04 | 354 | 174 | 10 | GO:0009925 |
| GeneOntologyCellularComponent | cell surface | CEACAM5 CALR ADAM20 WNT5A CUBN ITGB8 LRP8 THBS1 ICOS P2RX1 CSF2RB UMODL1 FZD5 LRP1 CD69 C5AR1 MDGA1 NOTCH2 PLXNB3 NOTCH4 | 9.70e-04 | 1111 | 174 | 20 | GO:0009986 |
| GeneOntologyCellularComponent | basal part of cell | ERBB2 CEACAM5 ERBIN WASF2 LRP1 C5AR1 ATP1B3 HSPA1A HSPA1B SLC14A2 | 1.30e-03 | 378 | 174 | 10 | GO:0045178 |
| GeneOntologyCellularComponent | anchoring junction | NPHS1 CEACAM5 CALR FBP2 IGSF11 ERBIN ITGB8 TGFB1I1 RND1 FZD5 WASF2 CPNE3 LRP1 DSG4 HSPA1A HSPA1B RPL4 IQGAP3 | 1.34e-03 | 976 | 174 | 18 | GO:0070161 |
| Domain | EGF_1 | RELN FBLN5 ZAN ADAM20 LAMA2 LAMA5 CUBN SSPOP ITGB8 SVEP1 LRP8 THBS1 EYS FBN2 UMODL1 LRP1 LTBP3 NOTCH2 NOTCH4 | 2.58e-12 | 255 | 172 | 19 | PS00022 |
| Domain | EGF_2 | RELN FBLN5 ZAN ADAM20 LAMA2 LAMA5 CUBN SSPOP ITGB8 SVEP1 LRP8 THBS1 EYS FBN2 UMODL1 LRP1 LTBP3 NOTCH2 NOTCH4 | 5.09e-12 | 265 | 172 | 19 | PS01186 |
| Domain | EGF | RELN FBLN5 ZAN LAMA2 LAMA5 CUBN ITGB8 SVEP1 LRP8 THBS1 EYS FBN2 FCGBP UMODL1 LRP1 LTBP3 NOTCH2 NOTCH4 | 6.31e-12 | 235 | 172 | 18 | SM00181 |
| Domain | EGF-like_dom | RELN FBLN5 ZAN ADAM20 LAMA2 LAMA5 CUBN SVEP1 LRP8 THBS1 EYS FBN2 FCGBP UMODL1 LRP1 LTBP3 NOTCH2 NOTCH4 | 1.66e-11 | 249 | 172 | 18 | IPR000742 |
| Domain | EGF-like_CS | RELN FBLN5 ZAN ADAM20 LAMA2 LAMA5 CUBN ITGB8 SVEP1 LRP8 THBS1 EYS FBN2 UMODL1 LRP1 LTBP3 NOTCH2 NOTCH4 | 3.64e-11 | 261 | 172 | 18 | IPR013032 |
| Domain | EGF_CA | FBLN5 CUBN SVEP1 LRP8 THBS1 FBN2 UMODL1 LRP1 LTBP3 NOTCH2 NOTCH4 | 3.94e-10 | 86 | 172 | 11 | PF07645 |
| Domain | EGF_3 | RELN FBLN5 ZAN ADAM20 CUBN SSPOP SVEP1 LRP8 THBS1 EYS FBN2 UMODL1 LRP1 LTBP3 NOTCH2 NOTCH4 | 5.68e-10 | 235 | 172 | 16 | PS50026 |
| Domain | EGF_CA | FBLN5 CUBN SVEP1 LRP8 THBS1 EYS FBN2 UMODL1 LRP1 LTBP3 NOTCH2 NOTCH4 | 1.37e-09 | 122 | 172 | 12 | SM00179 |
| Domain | EGF_Ca-bd_CS | FBLN5 CUBN SVEP1 LRP8 EYS FBN2 UMODL1 LRP1 LTBP3 NOTCH2 NOTCH4 | 1.47e-09 | 97 | 172 | 11 | IPR018097 |
| Domain | EGF-like_Ca-bd_dom | FBLN5 CUBN SVEP1 LRP8 THBS1 EYS FBN2 UMODL1 LRP1 LTBP3 NOTCH2 NOTCH4 | 1.65e-09 | 124 | 172 | 12 | IPR001881 |
| Domain | EGF_CA | FBLN5 CUBN SVEP1 LRP8 EYS FBN2 UMODL1 LRP1 LTBP3 NOTCH2 NOTCH4 | 1.83e-09 | 99 | 172 | 11 | PS01187 |
| Domain | ASX_HYDROXYL | FBLN5 CUBN SVEP1 LRP8 EYS FBN2 UMODL1 LRP1 LTBP3 NOTCH2 NOTCH4 | 2.04e-09 | 100 | 172 | 11 | PS00010 |
| Domain | Growth_fac_rcpt_ | ERBB2 FBLN5 LAMA5 CUBN SVEP1 LRP8 EYS FBN2 UMODL1 LRP1 LTBP3 NOTCH2 NOTCH4 | 2.16e-09 | 156 | 172 | 13 | IPR009030 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | FBLN5 CUBN SVEP1 LRP8 EYS FBN2 UMODL1 LRP1 LTBP3 NOTCH2 NOTCH4 | 3.82e-09 | 106 | 172 | 11 | IPR000152 |
| Domain | hEGF | 1.78e-07 | 28 | 172 | 6 | PF12661 | |
| Domain | ConA-like_dom | 6.06e-06 | 219 | 172 | 11 | IPR013320 | |
| Domain | EGF | 2.19e-05 | 126 | 172 | 8 | PF00008 | |
| Domain | - | 4.15e-05 | 8 | 172 | 3 | 3.90.290.10 | |
| Domain | TB_dom | 6.19e-05 | 9 | 172 | 3 | IPR017878 | |
| Domain | TB | 6.19e-05 | 9 | 172 | 3 | PS51364 | |
| Domain | AKAP_110 | 8.43e-05 | 2 | 172 | 2 | IPR020799 | |
| Domain | AKAP_110 | 8.43e-05 | 2 | 172 | 2 | SM00807 | |
| Domain | cEGF | 8.86e-05 | 26 | 172 | 4 | PF12662 | |
| Domain | cEGF | 8.86e-05 | 26 | 172 | 4 | IPR026823 | |
| Domain | C8 | 1.59e-04 | 12 | 172 | 3 | PF08742 | |
| Domain | TIL | 1.59e-04 | 12 | 172 | 3 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 2.05e-04 | 13 | 172 | 3 | IPR014853 | |
| Domain | C8 | 2.05e-04 | 13 | 172 | 3 | SM00832 | |
| Domain | - | 2.47e-04 | 95 | 172 | 6 | 2.60.120.200 | |
| Domain | TILa_dom | 2.51e-04 | 3 | 172 | 2 | IPR025615 | |
| Domain | AKAP_110_C | 2.51e-04 | 3 | 172 | 2 | IPR018292 | |
| Domain | Ryanodine_rcpt | 2.51e-04 | 3 | 172 | 2 | IPR003032 | |
| Domain | TILa | 2.51e-04 | 3 | 172 | 2 | PF12714 | |
| Domain | Ryanrecept_TM4-6 | 2.51e-04 | 3 | 172 | 2 | IPR009460 | |
| Domain | RyR | 2.51e-04 | 3 | 172 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 2.51e-04 | 3 | 172 | 2 | PF06459 | |
| Domain | Ryan_recept | 2.51e-04 | 3 | 172 | 2 | IPR013333 | |
| Domain | TIL_dom | 2.59e-04 | 14 | 172 | 3 | IPR002919 | |
| Domain | EamA | 2.59e-04 | 14 | 172 | 3 | PF00892 | |
| Domain | EamA_dom | 2.59e-04 | 14 | 172 | 3 | IPR000620 | |
| Domain | Ig_I-set | 3.86e-04 | 190 | 172 | 8 | IPR013098 | |
| Domain | I-set | 3.86e-04 | 190 | 172 | 8 | PF07679 | |
| Domain | VWF_type-D | 3.94e-04 | 16 | 172 | 3 | IPR001846 | |
| Domain | MAM_1 | 3.94e-04 | 16 | 172 | 3 | PS00740 | |
| Domain | VWFD | 3.94e-04 | 16 | 172 | 3 | PS51233 | |
| Domain | VWD | 3.94e-04 | 16 | 172 | 3 | SM00216 | |
| Domain | VWD | 3.94e-04 | 16 | 172 | 3 | PF00094 | |
| Domain | VWC | 4.02e-04 | 38 | 172 | 4 | SM00214 | |
| Domain | Notch | 5.00e-04 | 4 | 172 | 2 | IPR008297 | |
| Domain | NODP | 5.00e-04 | 4 | 172 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 5.00e-04 | 4 | 172 | 2 | IPR011656 | |
| Domain | MABP | 5.00e-04 | 4 | 172 | 2 | PS51498 | |
| Domain | G8_domain | 5.00e-04 | 4 | 172 | 2 | IPR019316 | |
| Domain | G8 | 5.00e-04 | 4 | 172 | 2 | PS51484 | |
| Domain | Aldehyde_DH_NAD(P) | 5.00e-04 | 4 | 172 | 2 | IPR012394 | |
| Domain | G8 | 5.00e-04 | 4 | 172 | 2 | SM01225 | |
| Domain | MABP | 5.00e-04 | 4 | 172 | 2 | IPR023341 | |
| Domain | SPHK1-interactor_AKAP_110 | 5.00e-04 | 4 | 172 | 2 | IPR008382 | |
| Domain | G8 | 5.00e-04 | 4 | 172 | 2 | PF10162 | |
| Domain | Notch_NOD_dom | 5.00e-04 | 4 | 172 | 2 | IPR010660 | |
| Domain | AKAP_110 | 5.00e-04 | 4 | 172 | 2 | PF05716 | |
| Domain | NOD | 5.00e-04 | 4 | 172 | 2 | PF06816 | |
| Domain | NOD | 5.00e-04 | 4 | 172 | 2 | SM01338 | |
| Domain | NODP | 5.00e-04 | 4 | 172 | 2 | SM01339 | |
| Domain | MAM | 5.66e-04 | 18 | 172 | 3 | PF00629 | |
| Domain | MAM_dom | 5.66e-04 | 18 | 172 | 3 | IPR000998 | |
| Domain | MAM_2 | 5.66e-04 | 18 | 172 | 3 | PS50060 | |
| Domain | VWF_dom | 5.92e-04 | 42 | 172 | 4 | IPR001007 | |
| Domain | VWC_out | 6.67e-04 | 19 | 172 | 3 | SM00215 | |
| Domain | PSI | 7.07e-04 | 44 | 172 | 4 | IPR016201 | |
| Domain | Laminin_domII | 8.28e-04 | 5 | 172 | 2 | IPR010307 | |
| Domain | RII_binding_1 | 8.28e-04 | 5 | 172 | 2 | PF10522 | |
| Domain | Laminin_aI | 8.28e-04 | 5 | 172 | 2 | IPR009254 | |
| Domain | Laminin_I | 8.28e-04 | 5 | 172 | 2 | PF06008 | |
| Domain | Laminin_II | 8.28e-04 | 5 | 172 | 2 | PF06009 | |
| Domain | LNR | 8.28e-04 | 5 | 172 | 2 | PS50258 | |
| Domain | RII_binding_1 | 8.28e-04 | 5 | 172 | 2 | IPR018459 | |
| Domain | PSI | 8.38e-04 | 46 | 172 | 4 | SM00423 | |
| Domain | - | 8.38e-04 | 46 | 172 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 9.85e-04 | 48 | 172 | 4 | PS01209 | |
| Domain | CUB | 1.07e-03 | 49 | 172 | 4 | PF00431 | |
| Domain | LDrepeatLR_classA_rpt | 1.07e-03 | 49 | 172 | 4 | IPR002172 | |
| Domain | LDLa | 1.07e-03 | 49 | 172 | 4 | SM00192 | |
| Domain | LDLRA_2 | 1.07e-03 | 49 | 172 | 4 | PS50068 | |
| Domain | CUB | 1.15e-03 | 50 | 172 | 4 | SM00042 | |
| Domain | RIH_assoc-dom | 1.23e-03 | 6 | 172 | 2 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.23e-03 | 6 | 172 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.23e-03 | 6 | 172 | 2 | PF08454 | |
| Domain | RIH_dom | 1.23e-03 | 6 | 172 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.23e-03 | 6 | 172 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.23e-03 | 6 | 172 | 2 | IPR015925 | |
| Domain | - | 1.23e-03 | 6 | 172 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.23e-03 | 6 | 172 | 2 | PF01365 | |
| Domain | - | NPHS1 FNDC3B CEACAM5 VSIG4 IGSF11 PLXND1 PKHD1L1 MFAP3L ICOS CSF2RB UMODL1 FGFR1 MDGA1 PLXNB3 CNTN1 | 1.24e-03 | 663 | 172 | 15 | 2.60.40.10 |
| Domain | - | 1.33e-03 | 52 | 172 | 4 | 2.60.120.290 | |
| Domain | Sushi | 1.33e-03 | 52 | 172 | 4 | PF00084 | |
| Domain | CUB | 1.43e-03 | 53 | 172 | 4 | PS01180 | |
| Domain | CCP | 1.53e-03 | 54 | 172 | 4 | SM00032 | |
| Domain | IGc2 | 1.53e-03 | 235 | 172 | 8 | SM00408 | |
| Domain | Ig_sub2 | 1.53e-03 | 235 | 172 | 8 | IPR003598 | |
| Pathway | WP_APOPTOSIS_MODULATION_BY_HSP70 | 2.09e-05 | 18 | 133 | 4 | MM15964 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HEXA ERBB2 IMPDH1 OFD1 LMTK2 LAMA5 PLXND1 TRRAP RYR1 KCNH3 PLCD3 RADIL RPAP1 PDCD11 ZFYVE26 FGFR1 LTBP3 LTK HERC2 IQGAP3 NOTCH2 SDHA RAI1 | 1.06e-08 | 1105 | 176 | 23 | 35748872 |
| Pubmed | DMXL2 RELN USP9X USP9Y ITGB8 DDX3X RYR3 THBS1 EHMT2 CADPS EIF4A2 NAV3 LRP1 SENP6 LTBP3 HERC2 UROD HSPA1A HSPA1B SDHA PLXNB3 SEZ6L RNF111 KPNA1 | 3.84e-08 | 1285 | 176 | 24 | 35914814 | |
| Pubmed | Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis. | 1.27e-07 | 3 | 176 | 3 | 21297664 | |
| Pubmed | Thrombospondin 1 binding to calreticulin-LRP1 signals resistance to anoikis. | 1.27e-07 | 3 | 176 | 3 | 18653767 | |
| Pubmed | 5.08e-07 | 4 | 176 | 3 | 9056918 | ||
| Pubmed | Emergence of primate genes by retrotransposon-mediated sequence transduction. | 5.08e-07 | 4 | 176 | 3 | 17101974 | |
| Pubmed | ERBB2 TBC1D2B LMTK2 LAMA5 PLXND1 ZFYVE28 SEMA5B CAPRIN2 MED12L KLHL42 SENP6 PDCD11 RAI1 ANKS1A | 5.83e-07 | 529 | 176 | 14 | 14621295 | |
| Pubmed | 8.28e-07 | 15 | 176 | 4 | 10964507 | ||
| Pubmed | 1.26e-06 | 5 | 176 | 3 | 28428949 | ||
| Pubmed | 1.68e-06 | 71 | 176 | 6 | 33541421 | ||
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 1.83e-06 | 18 | 176 | 4 | 12023983 | |
| Pubmed | CEACAM5 ZAN OFD1 CASP8 SLC35G6 DDX3X CEMIP FBN2 RND1 SLC35G3 SLC35G5 MDGA1 UTY PLS3 TBX5 | 1.97e-06 | 674 | 176 | 15 | 37196079 | |
| Pubmed | LAMA5 ERBIN SVEP1 DDX3X ZNF518A TGFB1I1 PLCD3 FBN2 LRP1 LTBP3 HERC2 NOTCH2 RNF111 KPNA1 | 2.14e-06 | 591 | 176 | 14 | 15231748 | |
| Pubmed | FNDC3B METTL3 CEACAM5 IMPDH1 RBM26 LAMA5 THOC3 TRRAP ALKBH5 ERBIN PLCD3 MSH6 ACAD11 EHMT2 WASF2 MIOS PDCD11 ATF1 HERC2 PLS3 IQGAP3 SDHA KPNA1 | 2.22e-06 | 1497 | 176 | 23 | 31527615 | |
| Pubmed | 2.34e-06 | 117 | 176 | 7 | 17145500 | ||
| Pubmed | 2.52e-06 | 6 | 176 | 3 | 16397188 | ||
| Pubmed | Regulation of Hsp90 client proteins by a Cullin5-RING E3 ubiquitin ligase. | 2.52e-06 | 6 | 176 | 3 | 19933325 | |
| Pubmed | Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex. | 2.52e-06 | 6 | 176 | 3 | 18957219 | |
| Pubmed | METTL3-mediated m6A modification is required for cerebellar development. | 3.55e-06 | 21 | 176 | 4 | 29879109 | |
| Pubmed | 4.84e-06 | 85 | 176 | 6 | 29228324 | ||
| Pubmed | 7.00e-06 | 8 | 176 | 3 | 10380922 | ||
| Pubmed | The Maternal Microbiome Programs the m6A Epitranscriptome of the Mouse Fetal Brain and Intestine. | 7.38e-06 | 25 | 176 | 4 | 35874829 | |
| Pubmed | DMXL2 SRSF1 USP9X GRM1 ERBIN DDX3X TXLNA EHMT2 WASF2 EIF4A2 LRP1 MIOS HERC2 RAI1 CNTN1 KPNA1 ANKS1A | 8.85e-06 | 963 | 176 | 17 | 28671696 | |
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 20554749 | ||
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | WNT5A FZD8 MSH6 EHMT2 FZD5 NCOA1 FGFR1 ATP1B3 RPL4 NOTCH2 NOTCH4 | 1.18e-05 | 424 | 176 | 11 | 21731673 |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.31e-05 | 101 | 176 | 6 | 23382219 | |
| Pubmed | 1.45e-05 | 214 | 176 | 8 | 22199357 | ||
| Pubmed | HIV-1 p17 and IFN-gamma both induce fructose 1,6-bisphosphatase. | 1.49e-05 | 10 | 176 | 3 | 9282826 | |
| Pubmed | Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. | 1.49e-05 | 10 | 176 | 3 | 17167422 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.58e-05 | 358 | 176 | 10 | 32460013 | |
| Pubmed | ERBB2 TRRAP ZNF518A MSH6 FBN2 ACAD11 EHMT2 CADPS CAPRIN2 LRP1 MTR LTK CSMD1 AGBL1 NOTCH2 RAI1 SEZ6L KPNA1 | 1.61e-05 | 1116 | 176 | 18 | 31753913 | |
| Pubmed | 1.88e-05 | 222 | 176 | 8 | 37071664 | ||
| Pubmed | 2.14e-05 | 371 | 176 | 10 | 25241761 | ||
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 2.55e-05 | 2 | 176 | 2 | 12411538 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 29442527 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 3786141 | ||
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 2.55e-05 | 2 | 176 | 2 | 26923070 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 16226104 | ||
| Pubmed | Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. | 2.55e-05 | 2 | 176 | 2 | 12871934 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 26976620 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 9489997 | ||
| Pubmed | The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance. | 2.55e-05 | 2 | 176 | 2 | 27323669 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 25240054 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 31974865 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 20235222 | ||
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 2.55e-05 | 2 | 176 | 2 | 20876613 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 20223214 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 2.55e-05 | 2 | 176 | 2 | 23704948 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 14991768 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 17513788 | ||
| Pubmed | IL-6 activates HSP72 gene expression in human skeletal muscle. | 2.55e-05 | 2 | 176 | 2 | 12207910 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 29572464 | ||
| Pubmed | Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. | 2.55e-05 | 2 | 176 | 2 | 12895410 | |
| Pubmed | A member of the Frizzled protein family mediating axis induction by Wnt-5A. | 2.55e-05 | 2 | 176 | 2 | 9054360 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 12714332 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 19299581 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 35671429 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 16971451 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 29631603 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 32400230 | ||
| Pubmed | Role of membrane Hsp70 in radiation sensitivity of tumor cells. | 2.55e-05 | 2 | 176 | 2 | 26197988 | |
| Pubmed | The Wingless homolog Wnt5a stimulates phagocytosis but not bacterial killing. | 2.55e-05 | 2 | 176 | 2 | 23012420 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 19157555 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 37298493 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 2.55e-05 | 2 | 176 | 2 | 17118445 | |
| Pubmed | Reelin supplementation enhances cognitive ability, synaptic plasticity, and dendritic spine density. | 2.55e-05 | 2 | 176 | 2 | 21852430 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 21142150 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 31969357 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 37454738 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 15498567 | ||
| Pubmed | The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair. | 2.55e-05 | 2 | 176 | 2 | 25367573 | |
| Pubmed | Geranylgeranylaceton induces heat shock protein 72 in skeletal muscle cells. | 2.55e-05 | 2 | 176 | 2 | 17482577 | |
| Pubmed | Dentate granule cells in reeler mutants and VLDLR and ApoER2 knockout mice. | 2.55e-05 | 2 | 176 | 2 | 12093079 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 12565913 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 28978351 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 9192302 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 12925892 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 7556644 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 30763736 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 3019832 | ||
| Pubmed | Sequence analysis of HSPA1A and HSPA1B in a multi-ethnic study population. | 2.55e-05 | 2 | 176 | 2 | 17364813 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 24430435 | ||
| Pubmed | The septic shock associated HSPA1B1267 polymorphism influences production of HSPA1A and HSPA1B. | 2.55e-05 | 2 | 176 | 2 | 15232679 | |
| Pubmed | Heat shock protein 72 supports extracellular matrix production in metastatic mammary tumors. | 2.55e-05 | 2 | 176 | 2 | 38703814 | |
| Pubmed | Human CD69 associates with an N-terminal fragment of calreticulin at the cell surface. | 2.55e-05 | 2 | 176 | 2 | 15893733 | |
| Pubmed | ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor. | 2.55e-05 | 2 | 176 | 2 | 10878805 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 15748471 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 20849898 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 22079349 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 19005184 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 23587900 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 16361353 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 17234954 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 3931075 | ||
| Pubmed | Heat-shock protein 70 genes and human longevity: a view from Denmark. | 2.55e-05 | 2 | 176 | 2 | 16804002 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 16735677 | ||
| Pubmed | HspA1A, a 70-kDa heat shock protein, differentially interacts with anionic lipids. | 2.55e-05 | 2 | 176 | 2 | 26476215 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 17126904 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 2868009 | ||
| Interaction | PIK3R2 interactions | ERBB2 USP9X VSIG4 DDX3X RND1 FGFR1 LTBP3 LTK ALDH3B1 HSPA1A HSPA1B ALK | 7.40e-07 | 230 | 173 | 12 | int:PIK3R2 |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.60e-04 | 3 | 133 | 2 | 287 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.08e-04 | 40 | 133 | 4 | 321 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 5.35e-04 | 51 | 133 | 4 | 870 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 6.74e-04 | 394 | 133 | 10 | 471 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 8.18e-04 | 57 | 133 | 4 | 1179 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.23e-03 | 161 | 133 | 6 | 593 | |
| GeneFamily | Copines | 1.87e-03 | 9 | 133 | 2 | 829 | |
| GeneFamily | Plexins | 1.87e-03 | 9 | 133 | 2 | 683 | |
| GeneFamily | Acyl-CoA dehydrogenase family | 2.83e-03 | 11 | 133 | 2 | 974 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 2.83e-03 | 11 | 133 | 2 | 286 | |
| GeneFamily | Laminin subunits | 3.38e-03 | 12 | 133 | 2 | 626 | |
| GeneFamily | Low density lipoprotein receptors | 3.97e-03 | 13 | 133 | 2 | 634 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.74e-07 | 191 | 175 | 10 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.53e-07 | 196 | 175 | 10 | M3008 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | FNDC3B ERBB2 RELN FBLN5 FSTL3 LAMA2 IGSF11 ITGB8 THBS1 LTBP3 PLXNB3 | 2.03e-06 | 268 | 175 | 11 | M45796 |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 8.47e-06 | 200 | 175 | 9 | M5930 | |
| Coexpression | NABA_CORE_MATRISOME | 1.47e-05 | 270 | 175 | 10 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.72e-05 | 275 | 175 | 10 | M5884 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 3.54e-05 | 135 | 175 | 7 | M5825 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN | 4.86e-05 | 193 | 175 | 8 | M4286 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CELF5 RELN RBM26 TBC1D2B LAMA5 GRM1 CSMD3 SSPOP CEMIP CADPS CELF3 CAPRIN2 RASGEF1B NAV3 ANKRD18A CSMD1 MDGA1 RAI1 SEZ6L CNTN1 | 5.28e-05 | 1106 | 175 | 20 | M39071 |
| Coexpression | GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP | 5.82e-05 | 198 | 175 | 8 | M5580 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN | 6.03e-05 | 199 | 175 | 8 | M6648 | |
| Coexpression | DESCARTES_FETAL_KIDNEY_MEGAKARYOCYTES | 7.52e-05 | 152 | 175 | 7 | M40227 | |
| Coexpression | BENPORATH_EED_TARGETS | RELN RIPK3 DHRS13 PLXND1 CSMD3 RYR3 KCNH3 CEMIP ZFYVE28 FZD8 FBN2 ANKRD18A LTK CSMD1 ATP1B3 MDGA1 HSPA1A HSPA1B TBX5 | 9.09e-05 | 1059 | 175 | 19 | M7617 |
| Coexpression | CHENG_IMPRINTED_BY_ESTRADIOL | 9.81e-05 | 110 | 175 | 6 | M19202 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | FNDC3B FBLN5 WNT5A LAMA2 LAMA5 SVEP1 THBS1 CSF2RB NFIA LRP1 FGFR1 LTBP3 CSMD1 HSPA1A HSPA1B PLS3 | 1.05e-06 | 466 | 169 | 16 | GSM777050_500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ZAN ABCA13 PKD1L2 GRM1 CSMD3 SSPOP PKHD1L1 RYR3 FBN2 OTOGL NAV3 CSMD1 CNTN1 | 2.30e-14 | 184 | 176 | 14 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ZAN ABCA13 PKD1L2 GRM1 CSMD3 SSPOP PKHD1L1 RYR3 FBN2 OTOGL NAV3 CSMD1 CNTN1 | 2.30e-14 | 184 | 176 | 14 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ZAN ABCA13 PKD1L2 GRM1 CSMD3 SSPOP PKHD1L1 RYR3 FBN2 OTOGL NAV3 CSMD1 CNTN1 | 2.30e-14 | 184 | 176 | 14 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 3.63e-10 | 146 | 176 | 10 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 8.37e-10 | 159 | 176 | 10 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-09 | 167 | 176 | 10 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 2.39e-09 | 129 | 176 | 9 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | FBLN5 WNT5A LAMA2 ALKBH5 THBS1 NFIA EIF4A2 FGFR1 LTBP3 NOTCH2 | 6.03e-09 | 195 | 176 | 10 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | FNDC3B USP9X ALKBH5 ERBIN DDX3X NFIA FGFR1 LTBP3 PLS3 NOTCH2 | 6.65e-09 | 197 | 176 | 10 | e77016d64b1cac9825fec7cfe5071f1567401187 |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FNDC3B USP9X ALKBH5 ERBIN DDX3X NFIA FGFR1 LTBP3 PLS3 NOTCH2 | 6.65e-09 | 197 | 176 | 10 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.80e-08 | 177 | 176 | 9 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | facs-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-08 | 180 | 176 | 9 | 72310baeed848f2c483ae986cd73d2fb2cca7feb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.61e-08 | 181 | 176 | 9 | 03a303cd2f366f09c18b118bbba6f5e3f95ad56c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.56e-08 | 185 | 176 | 9 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.10e-08 | 187 | 176 | 9 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.38e-08 | 188 | 176 | 9 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.68e-08 | 189 | 176 | 9 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.52e-08 | 197 | 176 | 9 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.94e-08 | 198 | 176 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-07 | 200 | 176 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-07 | 200 | 176 | 9 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-07 | 200 | 176 | 9 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-07 | 200 | 176 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-07 | 200 | 176 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-07 | 200 | 176 | 9 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.07e-07 | 156 | 176 | 8 | 2cd007b423c2395c5ce331902e7f27c805755eb3 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 3.65e-07 | 168 | 176 | 8 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.17e-07 | 171 | 176 | 8 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | 18-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 4.98e-07 | 175 | 176 | 8 | cc476b4244442418b8f21721a82a36209b556b36 | |
| ToppCell | 18-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 4.98e-07 | 175 | 176 | 8 | 7130b816e0c02309c161d8e9ad7cb4bc2469e251 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.66e-07 | 178 | 176 | 8 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.58e-07 | 185 | 176 | 8 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.55e-07 | 188 | 176 | 8 | 29d804232d974a8c0029300345b287005b09bade | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.55e-07 | 188 | 176 | 8 | a0873783f0a2cd852563c05a275dddc72905ced2 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 193 | 176 | 8 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 193 | 176 | 8 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-06 | 193 | 176 | 8 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 193 | 176 | 8 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.13e-06 | 195 | 176 | 8 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.17e-06 | 196 | 176 | 8 | 0aae78e73d53416d857bdf21f595a0a0a0ba7944 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 196 | 176 | 8 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-06 | 196 | 176 | 8 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.17e-06 | 196 | 176 | 8 | 5fe6534af65d43eeacd4b031310242b4f706008b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-06 | 197 | 176 | 8 | b0e2ea81308bce289cb7cbea0e27de1d01afeed2 | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.22e-06 | 197 | 176 | 8 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.31e-06 | 199 | 176 | 8 | 3895e367a33ac0316f96a64c07574de99684f4b7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-06 | 199 | 176 | 8 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 199 | 176 | 8 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-06 | 199 | 176 | 8 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-06 | 200 | 176 | 8 | 9156f8fd61a833891d2f7b7fadd693b81b1e2d5a | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.36e-06 | 200 | 176 | 8 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-06 | 200 | 176 | 8 | 5432bdf495431cd26f6e4cd585100f3652588913 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-06 | 200 | 176 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-06 | 200 | 176 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-06 | 200 | 176 | 8 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.36e-06 | 200 | 176 | 8 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.36e-06 | 200 | 176 | 8 | c74bc12e13d002dedaaf75a2244ec111e47524e1 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-06 | 200 | 176 | 8 | db6281b5d4032116310db379d9175d790994c99c | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-06 | 200 | 176 | 8 | 566fe2e78e6f35399ec6aad5964f6d4d8ade82c6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.36e-06 | 200 | 176 | 8 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Macc1_Lrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.59e-06 | 142 | 176 | 7 | d08e1880425d285c4433014fe0242ac7ff7734af | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 2.09e-06 | 148 | 176 | 7 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.09e-06 | 148 | 176 | 7 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.09e-06 | 148 | 176 | 7 | d5cace5605bff2bb8248fadb51f2dad7539930ba | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Tfh|blood / Manually curated celltypes from each tissue | 2.72e-06 | 154 | 176 | 7 | 5ff380205fa7ab97ba21f6512bc9e14c0fb320b6 | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 2.97e-06 | 156 | 176 | 7 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 2.97e-06 | 156 | 176 | 7 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.65e-06 | 161 | 176 | 7 | e3327c296d48e821004e61a573abb75624a6f040 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-06 | 161 | 176 | 7 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | 15-Distal-Immune-Immune|Distal / Age, Tissue, Lineage and Cell class | 3.81e-06 | 162 | 176 | 7 | e190c496ed1e206b86566edfee23c99a99fe90d0 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.96e-06 | 163 | 176 | 7 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-06 | 169 | 176 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-06 | 170 | 176 | 7 | 064786c1f1ad7665358964765910b0ad46d14685 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-06 | 170 | 176 | 7 | 6725747df336697708b94999b3ebb40f1721da16 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-06 | 171 | 176 | 7 | ac37c80c832504986c7a201d84f4b6aff5e5f323 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.43e-06 | 171 | 176 | 7 | 10492832db8ebc3cf85503c441f33bd94df9458e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.43e-06 | 171 | 176 | 7 | 7c0a1b0676f6749ee710c6bdeca6d6f7fac79b69 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-06 | 171 | 176 | 7 | b6502a81df4f25660f3ae4b7443a1d999df2d32b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.65e-06 | 172 | 176 | 7 | cc9d9dae290f11f8c348c78228af4e49469dc93b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.65e-06 | 172 | 176 | 7 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 5.86e-06 | 173 | 176 | 7 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.56e-06 | 176 | 176 | 7 | 6548797336c9f4ca0f38e74a2c629e2a4defa252 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.81e-06 | 177 | 176 | 7 | 68f1139fc378f351e3b9e9f392aacb150025bf03 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.07e-06 | 178 | 176 | 7 | 08b4a497aca0aeabf4f6a8a55c05b56417b69e78 | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.33e-06 | 179 | 176 | 7 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 7.60e-06 | 180 | 176 | 7 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 7.60e-06 | 180 | 176 | 7 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | Control-Myeloid-Alveolar_macrophages|Control / group, cell type (main and fine annotations) | 7.88e-06 | 181 | 176 | 7 | 8d2102c8c86c59a82610f26f90946b290552e666 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-B_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-06 | 181 | 176 | 7 | 3510e0ecd4f098e8553946c44c2a49587d543755 | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 8.17e-06 | 182 | 176 | 7 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.47e-06 | 183 | 176 | 7 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.77e-06 | 184 | 176 | 7 | 0efc757d9512d6a8fe8176e977a94e4494ed9778 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.77e-06 | 184 | 176 | 7 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-06 | 184 | 176 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.77e-06 | 184 | 176 | 7 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.41e-06 | 186 | 176 | 7 | 26458ff8cad5577de4306cffa0ca69eb26940e0d | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-06 | 186 | 176 | 7 | fddc6b93f98b10aaf8d4ebc142b46d8213f3129d | |
| ToppCell | facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.41e-06 | 186 | 176 | 7 | a71397efc68d2916ddc373d92cfd07be58033e1c | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.41e-06 | 186 | 176 | 7 | 6078aa16261554c7fd41137b8de1362d15b30490 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.75e-06 | 187 | 176 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| Drug | 2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A | DMXL2 RELN CABP2 FSTL3 VSIG4 TBC1D2B CASP8 USP9Y GRM1 MAP3K1 MIOS | 4.25e-07 | 199 | 175 | 11 | 3570_UP |
| Drug | Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; PC3; HT_HG-U133A | 3.40e-06 | 199 | 175 | 10 | 6687_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 3.55e-06 | 200 | 175 | 10 | 5921_DN | |
| Disease | Malignant neoplasm of breast | KPNA5 FNDC3B ERBB2 SRSF1 LAMA2 CASP8 CUBN MAP3K1 DDX3X MSH6 THBS1 SEMA5B OTOGL EIF4A2 MTR NCOA1 ZFYVE26 DLEC1 FGFR1 HERC2 HSPA1B ALK PLS3 NOTCH2 NOTCH4 | 2.10e-09 | 1074 | 167 | 25 | C0006142 |
| Disease | Schizophrenia | RELN SRSF1 ABCA13 LAMA2 GRM1 TRRAP LRP8 THBS1 CSF2RB LRP1 MTR FGFR1 ALDH3B1 CSMD1 MDGA1 HSPA1A HSPA1B ALK SDHA NOTCH4 RAI1 KPNA1 | 6.34e-09 | 883 | 167 | 22 | C0036341 |
| Disease | neuroimaging measurement | PDXDC1 RELN RBM26 RDH14 LAMA2 PLXND1 MAP3K1 LRP8 TG THBS1 FBN2 ACAD11 ST8SIA6 NFIA CADPS DENND4B NAV3 PDXDC2P ATP1B3 TUBD1 AGBL1 RAI1 ANKS1A | 4.18e-08 | 1069 | 167 | 23 | EFO_0004346 |
| Disease | severe acute respiratory syndrome, COVID-19 | RELN USP9X RBM26 WDFY4 TG ZFYVE28 EYS SEMA5B NFIA CADPS RASGEF1B LTBP3 CSMD1 TUBD1 PRDM6 | 4.33e-08 | 447 | 167 | 15 | EFO_0000694, MONDO_0100096 |
| Disease | cortical surface area measurement | CELF5 RELN ZAN RDH14 LAMA2 PLXND1 ITGB8 SVEP1 MAP3K1 LRP8 TG THBS1 FBN2 ACAD11 NFIA CADPS RASGEF1B NAV3 YDJC FGFR1 PLEKHM3 AGBL1 PRDM6 ANKS1A | 6.37e-07 | 1345 | 167 | 24 | EFO_0010736 |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 3.48e-06 | 41 | 167 | 5 | C0496956 | |
| Disease | Breast adenocarcinoma | 3.48e-06 | 41 | 167 | 5 | C0858252 | |
| Disease | cortical thickness | CELF5 RELN RDH14 LAMA2 PLXND1 MAP3K1 LRP8 TG THBS1 FBN2 NFIA UMODL1 CADPS NAV3 LRP1 DLEC1 FGFR1 ATP1B3 AGBL1 ANKS1A | 5.37e-06 | 1113 | 167 | 20 | EFO_0004840 |
| Disease | Sarcomatoid Renal Cell Carcinoma | 8.73e-06 | 128 | 167 | 7 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 8.73e-06 | 128 | 167 | 7 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 8.73e-06 | 128 | 167 | 7 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 8.73e-06 | 128 | 167 | 7 | C1306837 | |
| Disease | Renal Cell Carcinoma | 8.73e-06 | 128 | 167 | 7 | C0007134 | |
| Disease | brain measurement, neuroimaging measurement | PDXDC1 RDH14 MAP3K1 LRP8 TG THBS1 FBN2 ACAD11 CADPS NAV3 ATP1B3 AGBL1 ANKS1A | 1.63e-05 | 550 | 167 | 13 | EFO_0004346, EFO_0004464 |
| Disease | Unipolar Depression | 1.80e-05 | 259 | 167 | 9 | C0041696 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.24e-05 | 148 | 167 | 7 | C0279702 | |
| Disease | Paranoid Schizophrenia | 4.88e-05 | 13 | 167 | 3 | C0036349 | |
| Disease | Breast Carcinoma | ERBB2 CASP8 MAP3K1 THBS1 MTR NCOA1 FGFR1 HERC2 HSPA1B ALK NOTCH2 NOTCH4 | 6.08e-05 | 538 | 167 | 12 | C0678222 |
| Disease | Alzheimer disease, visuospatial impairment | 6.19e-05 | 14 | 167 | 3 | EFO_0009752, MONDO_0004975 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 9.52e-05 | 3 | 167 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 9.52e-05 | 3 | 167 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | tetradecenoylcarnitine meaasurement | 9.52e-05 | 3 | 167 | 2 | EFO_0021809 | |
| Disease | coronary artery disease | FNDC3B RDH14 SVEP1 MAP3K1 FBN2 ACAD11 NFIA STOML1 RASGEF1B LRP1 DLEC1 ATP1B3 SLC14A2 ALK PRDM6 RAI1 SEZ6L ANKS1A | 1.55e-04 | 1194 | 167 | 18 | EFO_0001645 |
| Disease | vitamin B12 deficiency (biomarker_via_orthology) | 1.90e-04 | 4 | 167 | 2 | DOID:0050731 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | ABCA13 CALR AKAP3 CASP8 CUBN GRM1 CSMD3 MSH6 FBN2 RPAP1 LRP1 BOLL CNTN1 | 1.92e-04 | 702 | 167 | 13 | C0009402 |
| Disease | Mammary Carcinoma, Human | ERBB2 CASP8 MAP3K1 THBS1 MTR NCOA1 FGFR1 HSPA1B ALK NOTCH2 NOTCH4 | 2.13e-04 | 525 | 167 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | ERBB2 CASP8 MAP3K1 THBS1 MTR NCOA1 FGFR1 HSPA1B ALK NOTCH2 NOTCH4 | 2.13e-04 | 525 | 167 | 11 | C1257931 |
| Disease | Mammary Neoplasms | ERBB2 CASP8 MAP3K1 THBS1 MTR NCOA1 FGFR1 HSPA1B ALK NOTCH2 NOTCH4 | 2.20e-04 | 527 | 167 | 11 | C1458155 |
| Disease | obesity (implicated_via_orthology) | 2.34e-04 | 215 | 167 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | Neoplasm Metastasis | 2.47e-04 | 217 | 167 | 7 | C0027627 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 3.15e-04 | 5 | 167 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | neuroblastoma (implicated_via_orthology) | 3.15e-04 | 5 | 167 | 2 | DOID:769 (implicated_via_orthology) | |
| Disease | airway responsiveness measurement | 3.30e-04 | 24 | 167 | 3 | EFO_0006897 | |
| Disease | Carcinoma, Pancreatic Ductal | 3.30e-04 | 24 | 167 | 3 | C0887833 | |
| Disease | complement C4b measurement | 3.74e-04 | 25 | 167 | 3 | EFO_0008092 | |
| Disease | Bipolar Disorder | 4.10e-04 | 477 | 167 | 10 | C0005586 | |
| Disease | Sjogren-Larsson syndrome (implicated_via_orthology) | 4.71e-04 | 6 | 167 | 2 | DOID:14501 (implicated_via_orthology) | |
| Disease | Major Depressive Disorder | 4.88e-04 | 243 | 167 | 7 | C1269683 | |
| Disease | memory performance | 5.65e-04 | 409 | 167 | 9 | EFO_0004874 | |
| Disease | peak expiratory flow | 5.73e-04 | 498 | 167 | 10 | EFO_0009718 | |
| Disease | FEV/FEC ratio | FNDC3B RDH14 ITGB8 MAP3K1 TG FCGBP RPAP1 CADPS LRP1 DLEC1 FGFR1 LTBP3 C5AR1 CSMD1 ZNF319 SLC14A2 TBX5 | 6.28e-04 | 1228 | 167 | 17 | EFO_0004713 |
| Disease | response to sulfonylurea, QT interval | 7.83e-04 | 32 | 167 | 3 | EFO_0004682, EFO_0007922 | |
| Disease | Large cell carcinoma of lung | 7.83e-04 | 32 | 167 | 3 | C0345958 | |
| Disease | aggressive behaviour measurement, childhood aggressive behaviour measurement | 7.83e-04 | 32 | 167 | 3 | EFO_0007663, EFO_0007826 | |
| Disease | Lung Neoplasms | 8.14e-04 | 265 | 167 | 7 | C0024121 | |
| Disease | Malignant neoplasm of lung | 8.32e-04 | 266 | 167 | 7 | C0242379 | |
| Disease | Head and Neck Neoplasms | 8.57e-04 | 33 | 167 | 3 | C0018671 | |
| Disease | cervical cancer | 9.37e-04 | 34 | 167 | 3 | C4048328 | |
| Disease | pulse pressure measurement | FNDC3B FBLN5 FSTL3 LAMA5 SSPOP SVEP1 PLCD3 FBN2 WASF2 LRP1 KLHL42 YDJC DLEC1 LTBP3 ATP1B3 SLC14A2 PRDM6 TBX5 | 9.52e-04 | 1392 | 167 | 18 | EFO_0005763 |
| Disease | schizophrenia (is_implicated_in) | 1.02e-03 | 78 | 167 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | cerebrospinal fluid clusterin measurement | 1.02e-03 | 35 | 167 | 3 | EFO_0007657 | |
| Disease | coronary aneurysm | 1.02e-03 | 35 | 167 | 3 | EFO_1000881 | |
| Disease | Uterine Cervical Neoplasm | 1.02e-03 | 35 | 167 | 3 | C0007873 | |
| Disease | retinal detachment (biomarker_via_orthology) | 1.12e-03 | 9 | 167 | 2 | DOID:5327 (biomarker_via_orthology) | |
| Disease | cysteine measurement | 1.12e-03 | 9 | 167 | 2 | EFO_0021000 | |
| Disease | Major depression, single episode | 1.12e-03 | 9 | 167 | 2 | C0024517 | |
| Disease | Head and Neck Carcinoma | 1.39e-03 | 10 | 167 | 2 | C3887461 | |
| Disease | glucagon-like peptide-1 measurement | 1.39e-03 | 10 | 167 | 2 | EFO_0008465 | |
| Disease | psoriatic arthritis | 1.53e-03 | 87 | 167 | 4 | EFO_0003778 | |
| Disease | Takayasu arteritis | 1.58e-03 | 148 | 167 | 5 | EFO_1001857 | |
| Disease | QRS duration | 1.60e-03 | 298 | 167 | 7 | EFO_0005055 | |
| Disease | Melancholia | 1.62e-03 | 41 | 167 | 3 | C0025193 | |
| Disease | Depression, Neurotic | 1.62e-03 | 41 | 167 | 3 | C0282126 | |
| Disease | atopic dermatitis (implicated_via_orthology) | 1.69e-03 | 11 | 167 | 2 | DOID:3310 (implicated_via_orthology) | |
| Disease | Depressive Syndrome | 1.74e-03 | 42 | 167 | 3 | C0086133 | |
| Disease | nevus count, cutaneous melanoma | 1.80e-03 | 91 | 167 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | Degenerative polyarthritis | 1.95e-03 | 93 | 167 | 4 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 1.95e-03 | 93 | 167 | 4 | C0086743 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.99e-03 | 156 | 167 | 5 | C0007131 | |
| Disease | Malignant Head and Neck Neoplasm | 1.99e-03 | 44 | 167 | 3 | C0278996 | |
| Disease | Mitral valve prolapse, response to surgery | 2.02e-03 | 12 | 167 | 2 | EFO_0009951, HP_0001634 | |
| Disease | Congenital muscular dystrophy | 2.02e-03 | 12 | 167 | 2 | cv:C0699743 | |
| Disease | dementia (is_implicated_in) | 2.02e-03 | 12 | 167 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | Myeloproliferative disease | 2.02e-03 | 12 | 167 | 2 | C0027022 | |
| Disease | albuminuria | 2.03e-03 | 94 | 167 | 4 | EFO_0004285 | |
| Disease | serum albumin measurement | PDXDC1 NPHS1 VSIG4 TBC1D2B ALKBH5 SVEP1 SEMA5B CPNE4 SLC14A2 NOTCH4 | 2.09e-03 | 592 | 167 | 10 | EFO_0004535 |
| Disease | Endogenous depression | 2.26e-03 | 46 | 167 | 3 | C0011573 | |
| Disease | homocysteine measurement | 2.26e-03 | 46 | 167 | 3 | EFO_0004578 | |
| Disease | Leber congenital amaurosis (implicated_via_orthology) | 2.38e-03 | 13 | 167 | 2 | DOID:14791 (implicated_via_orthology) | |
| Disease | Neoplasm of lung | 2.77e-03 | 14 | 167 | 2 | cv:C0024121 | |
| Disease | Hypodontia | 2.77e-03 | 14 | 167 | 2 | C0020608 | |
| Disease | Lung cancer | 2.77e-03 | 14 | 167 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 2.77e-03 | 14 | 167 | 2 | 211980 | |
| Disease | Prostatic Neoplasms | ERBB2 FBLN5 CALR LMTK2 MAP3K1 CPNE3 SENP6 NCOA1 HSPA1A ALOX12B | 2.78e-03 | 616 | 167 | 10 | C0033578 |
| Disease | Malignant neoplasm of prostate | ERBB2 FBLN5 CALR LMTK2 MAP3K1 CPNE3 SENP6 NCOA1 HSPA1A ALOX12B | 2.78e-03 | 616 | 167 | 10 | C0376358 |
| Disease | urate measurement, bone density | 2.87e-03 | 619 | 167 | 10 | EFO_0003923, EFO_0004531 | |
| Disease | melanoma | 2.97e-03 | 248 | 167 | 6 | C0025202 | |
| Disease | pro-hydroxy-pro measurement | 3.63e-03 | 16 | 167 | 2 | EFO_0021132 | |
| Disease | diffuse plaque measurement | RELN ABCA13 CSMD3 MSH6 EYS FBN2 EHMT2 CADPS NAV3 DLEC1 NOTCH4 | 4.06e-03 | 758 | 167 | 11 | EFO_0010699 |
| Disease | heart disease (biomarker_via_orthology) | 4.10e-03 | 17 | 167 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | glycochenodeoxycholate measurement | 4.10e-03 | 17 | 167 | 2 | EFO_0010490 | |
| Disease | sleep apnea measurement | 4.33e-03 | 116 | 167 | 4 | EFO_0007817 | |
| Disease | Polydactyly | 4.47e-03 | 117 | 167 | 4 | C0152427 | |
| Disease | Hypermetropia, Myopia | 4.52e-03 | 189 | 167 | 5 | HP_0000540, HP_0000545 | |
| Disease | Malignant neoplasm of skin | 4.59e-03 | 59 | 167 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 4.59e-03 | 59 | 167 | 3 | C0037286 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 4.81e-03 | 60 | 167 | 3 | C4722327 | |
| Disease | refractive error, age at onset, Myopia | 4.93e-03 | 193 | 167 | 5 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | rheumatoid arthritis | 4.96e-03 | 462 | 167 | 8 | EFO_0000685 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.15e-03 | 195 | 167 | 5 | DOID:1574 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GYEQLGLYCVLPLNQ | 96 | Q5DID0 | |
| GLYCVLPLNQSGQFT | 101 | Q5DID0 | |
| QGCQVVQGNLELTYL | 51 | P04626 | |
| GGVLIQRNPQLCYQD | 151 | P04626 | |
| DPCQDGIFISGQQNY | 1221 | Q96RT1 | |
| QQQREGPDGCNIFIY | 371 | Q5SZQ8 | |
| LECGANPNIEDIYGN | 121 | Q8IVF6 | |
| QCDPGYQLQGQAKIT | 1416 | Q96PZ7 | |
| YQCLPGFTLVGNAIL | 2421 | Q7Z407 | |
| RGVCKVDLYNPEGQQ | 21 | Q5JQC9 | |
| AYVKGICQNPFNTGV | 311 | O43506 | |
| VIYQPVEIAQDGGCV | 216 | Q8N9W6 | |
| FVNSAVINDYQPGGC | 186 | Q6P6C2 | |
| QYVDQSCFAVVLGGP | 156 | P43353 | |
| NDVGPYECGIQNELS | 386 | P06731 | |
| CVLAEIPQQVVGYFN | 506 | O75131 | |
| AGVLIGYCPQQDALD | 4796 | Q86UQ4 | |
| PCCVLQLGDIIDGYN | 66 | Q3LIE5 | |
| VARGYENVPIPCVNG | 926 | Q96KQ7 | |
| EVGQDPFQLLCTAGQ | 511 | Q92625 | |
| VLTGAVNPGDNCYSV | 6 | Q8TDJ6 | |
| YGNAVCIFEPLGINS | 76 | Q8TDJ6 | |
| YLDQSCFAVVLGGPQ | 76 | P48448 | |
| INCCINPIIYVVAGQ | 291 | P21730 | |
| RGIQLYDGPINIQNC | 876 | Q8WUJ3 | |
| IQVCGGAGVSQDYPL | 726 | Q709F0 | |
| YFRQDVLCQTLGGNP | 756 | Q96MI9 | |
| EQESKQNGIGINPYC | 456 | O15131 | |
| QNGIGINPYCALIEE | 461 | O15131 | |
| DLNNGSLVGPQIYLC | 76 | Q7Z401 | |
| QLVCPDAGQQAGQVG | 401 | Q12857 | |
| QQGQGYCQPDAAVRT | 316 | Q7Z5J4 | |
| NLQVAYNGDPEGALI | 561 | Q5T8P6 | |
| NGLINGNVVPCNGEI | 571 | O75665 | |
| LGNAQVAGLFPVVYC | 31 | Q9ULD8 | |
| AIVCGLVVYADGPLN | 231 | Q9HCC9 | |
| ACGNINVNIIYGLTV | 171 | P0C646 | |
| QAGQYVLCDVVGQAG | 106 | Q96JH8 | |
| IALIALSVGQYNCPG | 56 | Q07108 | |
| CRGQGVYAPAQAQIV | 16 | Q8NFP4 | |
| CAYNFGQPVQGETQI | 226 | Q6IE37 | |
| PGQVFVLDEYCARNG | 706 | Q9ULU8 | |
| RPCVVYGGADIGQQI | 296 | O00571 | |
| PYLVGQVVAGAQALQ | 201 | P06132 | |
| AGAYQCIVDNGVAPP | 811 | O60500 | |
| KGALCDTNPLNGQYI | 386 | Q04721 | |
| GNSALINCSVYGIPD | 61 | O75121 | |
| LNPDQTAQVFEGLCG | 896 | Q86YW9 | |
| QSLQNCGEGVADPSY | 1181 | Q9BXT6 | |
| LCAPGYTGINCEINL | 991 | Q5T1H1 | |
| EKGLQNVDFYLCPGN | 121 | P61550 | |
| YANVIGPIQCEGLAN | 436 | O95714 | |
| FICGCVEGYLLQPDN | 171 | Q07954 | |
| QLQNAIGAAPVDGEY | 296 | P14091 | |
| IQGNICVPAELADYN | 946 | Q86SJ6 | |
| ECNPVAYIIEQAGGL | 281 | O00757 | |
| LYILVGQQGEDACPG | 156 | P29376 | |
| QVCNPIISGLYQGAG | 601 | P0DMV9 | |
| AIQPGCINYDLVKSG | 561 | P13797 | |
| YVEVPLACQGQGLIQ | 276 | Q9ULL4 | |
| DPGQGLVVVCGSIYQ | 131 | Q9Y4D7 | |
| AARPGLGQYLCNQLG | 181 | Q6P996 | |
| AARPGLGQYLCNQLG | 181 | Q6P474 | |
| LPCGYLVGDNNIITV | 2001 | Q8IVL0 | |
| NILQCVGQCVEAIPY | 196 | Q8IWU2 | |
| YGIVKGLPNDCQQCA | 1456 | P24043 | |
| GGDPNQTIRGQYCDI | 91 | O15230 | |
| GFICEICNNGEILYP | 681 | Q6ZWE6 | |
| EQENGKAYCVLVTGP | 1121 | P52701 | |
| GPCIIYNEDNGIIKA | 206 | P36578 | |
| IYFLNEGCANRLPNG | 381 | Q0VAM2 | |
| GVVPDCANGYQRALE | 641 | Q86VI3 | |
| PQGFNQGLDCDVIVA | 491 | Q86U44 | |
| YGCLITPNNRNQGVL | 2581 | P78509 | |
| CGLGQVIQVQDAVYG | 171 | Q7Z442 | |
| FVPYLIAGIQHGCQD | 456 | P20839 | |
| PGLAYGICAAQRIQQ | 256 | Q9NQX0 | |
| GGVQILCKYPDIVQQ | 36 | Q9Y6W8 | |
| VQGIYFNITAICPDG | 396 | P26012 | |
| SCNQGDYLVLRNGPD | 2146 | O60494 | |
| VDGDPVAGICYVGNQ | 381 | Q13467 | |
| VAGICYVGNQNLNSL | 386 | Q13467 | |
| PVAGICYVGNQSLDN | 466 | Q9H461 | |
| GTYQCLVNNLPDIGG | 116 | Q5DX21 | |
| LEYLCLPAGGQVQLV | 626 | P32927 | |
| YLCVQSPAGLNGFNV | 706 | Q96AV8 | |
| QYKLEVQCPQGGAAV | 571 | Q9Y6W3 | |
| NLLGACTQDGPLYVI | 546 | P11362 | |
| SGFLYNGQACVPIQQ | 2771 | Q9Y6R7 | |
| DSGFLYNGQACVPIQ | 3971 | Q9Y6R7 | |
| PGQELCGNNNVTYIS | 206 | O95633 | |
| NQAGAGPYSELVLCQ | 841 | Q53EP0 | |
| PECAGIQGVVEAYQS | 386 | Q96A23 | |
| QQQREGPEGCNLFIY | 391 | Q8N6W0 | |
| GQNVTLECFALGNPV | 256 | Q12860 | |
| QNIDCGGGYVKLFPN | 101 | P27797 | |
| ACAAGQLNYVDPATG | 86 | Q5VUE5 | |
| FIQACQGDNYQKGIP | 356 | Q14790 | |
| DLQLGRFNCPVNGTY | 1031 | Q6IMN6 | |
| PCIKGYDVIAQAQSG | 66 | Q14240 | |
| CPDGKGYTQDNNIVN | 971 | Q9NS15 | |
| ATGAVGQYTVQCPQD | 46 | O75342 | |
| GQYTVQCPQDLGELI | 51 | O75342 | |
| TVEDCGSLVNGQPQY | 26 | Q86UD3 | |
| ALGEEVPQGYTCIQA | 56 | O75064 | |
| QKVILDGYGSCGPQN | 96 | Q7Z2F6 | |
| QVCNPIISGLYQGAG | 601 | P0DMV8 | |
| NQNGGYLCIPRTNPV | 61 | Q9UBX5 | |
| ENGQCLNVPGAYRCE | 1461 | P35556 | |
| NCVNGLCVNTPGRYE | 1541 | P35556 | |
| CNTSNLGVVAPLGYN | 746 | Q13255 | |
| GPYQQLCIDITGCAN | 1196 | Q9Y238 | |
| EYIQGPCTGNQQSLA | 3966 | P21817 | |
| QGYSVLNSLVGPACI | 46 | Q9NPB3 | |
| GAQTPLYCALQEGIE | 261 | Q6UX07 | |
| ELSVQPNGGCEYLCL | 691 | Q14114 | |
| VVDPCNINQQNIGYA | 661 | Q3ZCN5 | |
| GENGKTICYVQDNLP | 376 | Q9Y5E1 | |
| NIIYVNGSVPGHKNC | 281 | P09001 | |
| GVQAQPLNVGFCEQE | 511 | P06865 | |
| IGGVDYVLNCILGNQ | 731 | Q13233 | |
| LCPVFQLGYVVQESG | 226 | P51575 | |
| GCAYSAVQVVPAGNA | 116 | Q96KT7 | |
| SNCPVAYQILQGNGD | 2396 | Q93008 | |
| CIAGSESNGNVPYLQ | 546 | O14607 | |
| GCAYSAVQVVPAGNA | 116 | Q8N808 | |
| LACDNPGLPENGYQI | 871 | Q9BYH1 | |
| YCEGPRAQGEVCQAL | 3291 | A2VEC9 | |
| LSGVVGNCVNGVANY | 221 | Q86VL8 | |
| GNCVNGVANYALVSV | 226 | Q86VL8 | |
| NGQDQIVPGLYACGE | 426 | P31040 | |
| YQCENGVSGPSQDLL | 291 | Q99593 | |
| GLSQLQEAAPGAVYQ | 266 | Q58EX7 | |
| PISYEQGCAIAKQLG | 146 | Q92730 | |
| QEAKRNGTGINPYCA | 456 | P52294 | |
| NGTGINPYCALIEEA | 461 | P52294 | |
| VQCTVNLVGGDPYLN | 1396 | Q15788 | |
| NQVGAGGEPLDACYL | 76 | Q9Y2N7 | |
| DTNNPNVNYGIVVDC | 81 | Q9Y227 | |
| GPYTNFVNIGERCNV | 366 | Q99707 | |
| YPYNQCAVVGNGGIL | 181 | P61647 | |
| AQRGCQLLVYPGAFN | 166 | Q9NQR4 | |
| LDVLINNAGIFQCPY | 136 | Q9HBH5 | |
| GFQLVGNPVQYCLNQ | 1661 | Q4LDE5 | |
| VNGGVCLATYPQIQC | 166 | Q99466 | |
| VPSELGGVGLCNTQY | 146 | P49748 | |
| LYILVGQQGEDACPS | 771 | Q9UM73 | |
| QNGVCKVDVYSPGDN | 11 | O75969 | |
| SGQYIAIAPNGALQL | 106 | P18846 | |
| GALFEQKGPVYVACQ | 131 | P54709 | |
| LNNNGYDGIVIAINP | 26 | Q9Y6N3 | |
| GCIVKFYNNVQGLVP | 556 | Q14690 | |
| VQLGQCGNQIGFEVF | 6 | Q9UJT1 | |
| LVQTVNCDPGLAVGY | 986 | P07996 | |
| NYDPECLLAVGQANG | 71 | Q9NXC5 | |
| GPSYVQNCVKENQGI | 101 | Q6ZNA4 | |
| GRPLVNIYNCSGVQV | 446 | Q9Y572 | |
| GACYQFNVVLPSGTQ | 311 | Q9UBI4 | |
| GCQLVALNFQTPGYE | 606 | Q8N3E9 | |
| ANGKELGTCYQVEPN | 1426 | Q15413 | |
| LTEYIQGPCIGNQQS | 3816 | Q15413 | |
| RPEQGYCQAQGPVAA | 171 | Q8IV04 | |
| NGNGCINILSYPELK | 201 | Q96J01 | |
| VINKLGPRYCGNFQA | 1251 | Q6ZS81 | |
| PGVCQVFAEALQAYG | 141 | A8MPS7 | |
| VPQQNNFSDCGVYVL | 1021 | Q9GZR1 | |
| YIIGAQPLCSQLAGL | 61 | P41221 | |
| RNGGLPCVGDAAEYQ | 886 | Q9P283 | |
| QVEVYVNGIPAKCSG | 1041 | Q86WI1 | |
| FSSCPVAYQILQGNG | 2396 | O00507 | |
| QNLGNNYSDEPCIGQ | 351 | Q9Y279 | |
| PCIGQEYQIIAQING | 361 | Q9Y279 | |
| NYGNCELPVESSNQG | 621 | Q6AHZ1 | |
| APGLQNYFLQCVAPG | 921 | Q9BWH6 | |
| GCAYSAVQVVPAGNA | 116 | P0C7Q6 | |
| PTLVYQNGSIGCVEN | 226 | Q9Y6W5 | |
| AYLFNSVVNVGCGPA | 56 | Q96NS1 | |
| AENPLGCAVYGILLQ | 41 | Q9P2F9 | |
| AGNNDCRIYVGNLPP | 11 | Q07955 | |
| GKVQCYGRELNQPAS | 1516 | Q5VWN6 | |
| CQGCQGPILDNYISA | 346 | O43294 | |
| RAIPVGIGQVYGCDN | 746 | Q15849 | |
| RNGDYQAVQCQTEGP | 321 | P01266 | |
| LAQACVPQLQEGQGD | 31 | Q68DK2 | |
| NPDIGYCQGLNRLVA | 746 | Q9UPU7 | |
| VEQPNQVNYGNICTG | 2156 | Q9Y4A5 | |
| DILSTYCVDNNQGGP | 81 | P40222 | |
| LQAYASLCAQAGQAP | 1786 | Q9Y493 | |
| QNGNITQIPEYGDTC | 216 | Q3MJ62 | |
| IGGQAVSNVECYNPE | 306 | Q9P2K6 |